Use of prostacyclin antagonists for treating ocular surface nociception
AssigneeJenivision Inc.
InventorsDAVID FREDERICK WOODWARD, WEIZHEN WANG
Life of this patent
Estimating the term…
Abstract
The present invention relates generally to the use of compositions and methods for treating nociceptive events that occur on the ocular surface in association with dryness, injury, environmental pollutants, and infectious and non-infectious diseases. Specifically, the present invention is directed to the use of certain compounds for treating for treating ocular pain or ocular discomfort.
Claims6
-21. (canceled)
A pharmaceutical composition for topical ophthalmic administration comprising 4,5-dihydro-N-[4-[[4-(1-methylethoxy)phenyl]methyl]phenyl]-1H-imadazol-2-amine, or an ophthalmically acceptable salt thereof, wherein the 4,5-dihydro-N-[4-[[4-(1-methylethoxy)phenyl]methyl]phenyl]-1H-imadazol-2-amine is present in a concentration from about 0.003% (w/v) to about 5% (w/v), and wherein said composition is a solution.
Dependencies are inferred from the claim text.